Furthermore, it is likely that FGF23 has indirect effects on skeletal muscle, as FGF23 is interconnected with various established mechanisms of CKD-associated sarcopenia, such as the induction of local and systemic inflammation, of oxidative stress, and of abnormalities in adipokine metabolism [320]. The gene discussed is FGF23; the disease is chronic kidney disease.